T-cell responses to KSHV infection: a systematic approach.

Autor: Roshan R; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Labo N; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Trivett M; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Miley W; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Marshall V; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Coren L; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Cornejo Castro EM; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Perez H; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Holdridge B; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Davis E; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Matus-Nicodemos R; Vaccine Research Center, National Institute of Allergy and Infectious Disease, Bethesda, MD, USA., Ayala VI; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Sowder R 2nd; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Wyvill KM; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, USA., Aleman K; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, USA., Fennessey C; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Lifson J; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Polizzotto MN; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, USA., Douek D; Vaccine Research Center, National Institute of Allergy and Infectious Disease, Bethesda, MD, USA., Keele B; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Uldrick TS; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, USA., Yarchoan R; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, USA., Ohlen C; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Ott D; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Whitby D; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.

Publikováno v: Oncotarget [Oncotarget] 2017 Nov 25; Vol. 8 (65), pp. 109402-109416. Date of Electronic Publication: 2017 Nov 25 (Print Publication: 2017).